Date

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus.  The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

During this event, MHD is adding two additional albuterol inhalers as preferred products. The list of preferred beta adrenergic short acting inhalers is:

  • ProAirâ HFA
  • Proventilâ HFA
  • Ventolinâ HFA
  • Xopenex HFAâ

MHD is currently completing system work for these to process without a call to the helpdesk, which should be completed by the end of the day on March 20, 2020.